Horizon is a biopharmaceutical company focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives.
Horizon's global headquarters is in Dublin, Ireland. The Company also has offices in Lake Forest, Ill.; Chicago, Ill.; Brisbane, Calif.; Novato, Calif.; Washington, D.C. and Mannheim, Germany.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Sep 16, 2020 at 12:30 PM EDT
Morgan Stanley 18th Annual Global Healthcare Conference (Virtual)
Aug 5, 2020 at 8:00 AM EDT
Horizon Therapeutics Second Quarter 2020 Earnings Call
Jul 31, 2020 at 9:00 AM EDT
New TEPEZZA OPTIC-X and OPTIC Trial Data
Jun 23, 2020 at 10:30 AM EDT
BMO 2020 Prescriptions for Success Healthcare Conference (Virtual)
Jun 4, 2020 at 3:00 PM EDT
KRYSTEXXA Immunomodulation Strategy and EULAR Data